Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CENTENE CORPCNC · Entity 3133 | Director | July 28, 2026 | July 28, 2026 |
| DAVITA INC.DVA · Entity 3482 | Director | May 15, 2023 | May 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CENTENE CORP
Report date July 28, 2026 · Filed July 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,771 |
Reported balance
After 2026-07-28 transaction · row 1
1 source rowRow 1 · 2026-07-28 · Grant · Acquired 2,771 · Balance 2,771 F1: This award includes 2,771 shares of restricted stock units which will vest in full on the date of the Registrant's 2027 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: This award includes 2,771 shares of restricted stock units which will vest in full on the date of the Registrant's 2027 annual meeting of stockholders.
DAVITA INC.
Report date May 15, 2023 · Filed May 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,069 |
Reported balance
After 2023-05-15 transaction · row 1
1 source rowRow 1 · 2023-05-15 · Grant · Acquired 516 · Balance 16,069 |
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KINDRED HEALTHCARE, INC
Report date July 02, 2018 · Filed July 02, 2018
Section 16 reporting ended · disclosed 2018-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-02 transaction · row 1
1 source rowRow 1 · 2018-07-02 · Disposition to issuer · Disposed 424,340 · Balance 0 |
MYRIAD GENETICS INC
Report date April 30, 2025 · Filed April 30, 2025
Section 16 reporting ended · disclosed 2025-04-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 891,844 |
Reported balance
Holding disclosure · report date 2025-04-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 891,844 |
| Time-Based Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $13.38 · Expires 2027-08-13 | Direct | 342,040 |
Reported balance
Holding disclosure · report date 2025-04-30 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 342,040 |
| Performance-Based Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $13.38 · Expires 2027-08-13 | Direct | 339,088 |
Reported balance
Holding disclosure · report date 2025-04-30 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 339,088 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2020 Filed Dec 2, 2020 23:31 UTC | DAVITA INC. DVA · Entity 3482 | Disposition to issuerCommon Stock | 4,323 | $109.88 | $475,011.24 |
DisclosureSEC source: 0000927066-20-000259 · wf-form4_160695187731295.xml · nonDerivative · entry 6 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,554 Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 23:31 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionCommon Stock | 7,165 | $66.29 | $474,967.85 |
DisclosureSEC source: 0000927066-20-000259 · wf-form4_160695187731295.xml · nonDerivative · entry 5 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 23:31 UTC | DAVITA INC. DVA · Entity 3482 | Disposition to issuerCommon Stock | 4,323 | $109.88 | $475,011.24 |
DisclosureSEC source: 0000927066-20-000259 · wf-form4_160695187731295.xml · nonDerivative · entry 4 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,712 Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 23:31 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionCommon Stock | 7,178 | $66.17 | $474,968.26 |
DisclosureSEC source: 0000927066-20-000259 · wf-form4_160695187731295.xml · nonDerivative · entry 3 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 23:31 UTC | DAVITA INC. DVA · Entity 3482 | Disposition to issuerCommon Stock | 3,459 | $109.88 | $380,074.92 |
DisclosureSEC source: 0000927066-20-000259 · wf-form4_160695187731295.xml · nonDerivative · entry 2 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,857 Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 23:31 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionCommon Stock | 5,015 | $75.77 | $379,986.55 |
DisclosureSEC source: 0000927066-20-000259 · wf-form4_160695187731295.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2020 Filed Nov 18, 2020 02:15 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-20-000247 · wf-form4_160566572710383.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,301 Read SEC document |
| August 15, 2020 Filed Aug 18, 2020 22:14 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 578 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-20-000187 · wf-form4_159778887567985.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,871 Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 22:08 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantTime-Based Stock Option · Derivative | 342,040 | $0.00 Strike: $13.38 | $0.00 |
DisclosureSEC source: 0000899243-20-022446 · doc4.xml · derivative · entry 3 DIAZ PAUL J · CIK 0001194247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,040 Underlying: Common Stock · 342,040 shares Expires 2027-08-13 F3 · derivative.exercise_date: The shares subject to the Time-Based Stock Option will vest as to 25% of the shares on each of August 13, 2021, August 13, 2022, August 13, 2023 and August 13, 2024. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 22:08 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantPerformance-Based Stock Option · Derivative | 339,088 | $0.00 Strike: $13.38 | $0.00 |
DisclosureSEC source: 0000899243-20-022446 · doc4.xml · derivative · entry 2 DIAZ PAUL J · CIK 0001194247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,088 Underlying: Common Stock · 339,088 shares Expires 2027-08-13 F2 · derivative.exercise_date: The shares subject to the Performance-Based Stock Option become eligible to vest upon achievement of certain stock price targets and will vest as to 20% of the shares upon achievement of each of five stock price targets; provided that no portion of the Performance-Based Stock Option may vest earlier than August 13, 2021. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 22:08 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 298,954 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-022446 · doc4.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,954 F1 · kind: Consists of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests as to 50% of the shares on August 13, 2021, 16.66% of the shares on August 13, 2022, 16.66% of the shares on August 13, 2023, and 16.68% of the shares on August 13, 2024. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:22 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionStock Appreciation Rights · Derivative | 4,662 | $0.00 Strike: $81.51 | $0.00 |
DisclosureSEC source: 0000927066-20-000135 · wf-form4_159182772541556.xml · derivative · entry 3 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,662 shares Expires 2020-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Stock Appreciation Rights were granted on June 16, 2015, and 100% vested on June 16, 2016. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:22 UTC | DAVITA INC. DVA · Entity 3482 | Disposition to issuerCommon Stock | 4,305 | $88.28 | $380,045.40 |
DisclosureSEC source: 0000927066-20-000135 · wf-form4_159182772541556.xml · nonDerivative · entry 2 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,293 Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:22 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionCommon Stock | 4,662 | $81.51 | $379,999.62 |
DisclosureSEC source: 0000927066-20-000135 · wf-form4_159182772541556.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2020 Filed May 20, 2020 01:19 UTC | DAVITA INC. DVA · Entity 3482 | GiftCommon Stock | 4,050 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-20-000106 · wf-form4_158993753765484.xml · nonDerivative · entry 5 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,936 Read SEC document |
| May 18, 2020 Filed May 20, 2020 01:19 UTC | DAVITA INC. DVA · Entity 3482 | SaleCommon Stock | 307 | $81.61 | $25,054.85 |
DisclosureSEC source: 0000927066-20-000106 · wf-form4_158993753765484.xml · nonDerivative · entry 4 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,986 Read SEC document |
| May 18, 2020 Filed May 20, 2020 01:19 UTC | DAVITA INC. DVA · Entity 3482 | SaleCommon Stock | 635 | $82.16 | $52,173.06 |
DisclosureSEC source: 0000927066-20-000106 · wf-form4_158993753765484.xml · nonDerivative · entry 3 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,293 Read SEC document |
| May 18, 2020 Filed May 20, 2020 01:19 UTC | DAVITA INC. DVA · Entity 3482 | SaleCommon Stock | 4,821 | $82.26 | $396,597.15 |
DisclosureSEC source: 0000927066-20-000106 · wf-form4_158993753765484.xml · nonDerivative · entry 2 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,928 Read SEC document |
| May 15, 2020 Filed May 20, 2020 01:19 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 599 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-20-000106 · wf-form4_158993753765484.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,749 Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 23:57 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-20-000051 · wf-form4_158448941911494.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,150 Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 23:25 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 671 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-19-000195 · wf-form4_157420594322892.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,525 Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 22:18 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 814 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-19-000149 · wf-form4_156599390089683.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,854 Read SEC document |
| May 15, 2019 Filed May 17, 2019 23:26 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 946 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-19-000080 · wf-form4_155813559934305.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,040 Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:30 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 437 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-19-000042 · wf-form4_155433782332723.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,094 Read SEC document |
| December 31, 2018 Filed Jan 4, 2019 00:14 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 462 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-19-000013 · wf-form4_154656085328967.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,657 Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 17:56 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 332 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-18-000179 · wf-form4_153850295325744.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,195 Read SEC document |
| July 02, 2018 Filed Jul 2, 2018 13:03 UTC | KINDRED HEALTHCARE, INC KND · Entity 165258 | Disposition to issuerCommon Stock | 424,340 | $9.00 | $3,819,060.00 |
DisclosureSEC source: 0001209191-18-040209 · doc4.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 23:45 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 342 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-18-000148 · wf-form4_153066149062719.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,863 Read SEC document |
| May 15, 2018 Filed May 17, 2018 23:07 UTC | DAVITA INC. DVA · Entity 3482 | GrantStock Appreciation Rights · Derivative | 7,165 | $0.00 Strike: $66.29 | $0.00 |
DisclosureSEC source: 0000927066-18-000094 · wf-form4_152659838688163.xml · derivative · entry 2 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,165 Underlying: Common Stock · 7,165 shares Expires 2023-05-15 Read SEC document |
| March 31, 2018 Filed Apr 4, 2018 01:52 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 360 | $65.94 | $23,738.40 |
DisclosureSEC source: 0000927066-18-000042 · wf-form4_152280673479880.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,521 Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 13:11 UTC | KINDRED HEALTHCARE, INC KND · Entity 165258 | GrantCommon Stock | 2,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010703 · doc4.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,340 F1 · shares: These shares represent common stock granted to the reporting person in satisfaction of vested Performance Units. Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 00:52 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 329 | $72.25 | $23,770.25 |
DisclosureSEC source: 0000927066-18-000016 · wf-form4_151502716462109.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,161 Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 16:24 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-17-000071 · wf-form4_150704782936525.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,832 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 23:45 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-17-000042 · wf-form4_149929830525020.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,432 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 22:29 UTC | DAVITA INC. DVA · Entity 3482 | GrantStock Appreciation Rights · Derivative | 7,178 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000927066-17-000015 · wf-form4_149799775311735.xml · derivative · entry 2 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 Underlying: Common Stock · 7,178 shares Expires 2022-06-16 Read SEC document |
| May 24, 2017 Filed May 25, 2017 12:18 UTC | KINDRED HEALTHCARE, INC KND · Entity 165258 | GrantCommon Stock | 14,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035217 · doc4.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,118 F1 · shares: These shares represent restricted stock granted to the reporting person. These shares will fully vest on 5/24/2018. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:39 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 349 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-005685 · edgar.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,065 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 16:54 UTC | KINDRED HEALTHCARE, INC KND · Entity 165258 | GrantCommon Stock | 8,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012765 · doc4.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,266 F1 · shares: These shares represent common stock granted to the reporting person in satisfaction of vested Performance Units. Read SEC document |
| December 31, 2016 Filed Jan 5, 2017 00:09 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 370 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000374 · edgar.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,716 Read SEC document |
| September 30, 2016 Filed Oct 5, 2016 00:41 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 359 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-030401 · edgar.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,346 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.